Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium

Clinical trial NCT06399679 · SUSPENDED

Trial details

NCT number: NCT06399679
Sponsor: Washington University School of Medicine
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Anticholinergic Toxicity

Start date: 2024-11-04
Primary completion: 2028-11-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.